Database for Interstitial Lung Disease
Recruiting
Observational Study
Lung Diseases, Interstitial
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 412 (estimated)
- Sponsor
- Medical University of Graz · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age: ≥ 18 years
* patients with a known systemic disease bearing a risk for ILD
* signed informed consent (for prospective part)
Exclusion Criteria:
* Age \< 18 years
* comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)
Contacts